“
“Purpose: Guinea pig sensitization assays provide a critical tool in toxicological testing. Here, we investigate the relative sensitivities of the Guinea Pig Maximization Test (GPMT), the Open Epicutaneous Test (OET), and

the Buehler test on seven common compounds.

Methods: Seven compounds (formalin, nickel sulfate, 2-benzothiazolethiol, neomycin sulfate, potassium dichromate, ethylenediamine, dihydrochloride, and cinnamyl alcohol) were investigated on 15 guinea pigs per assay. XMU-MP-1 price Differences between each assay were investigated individually for each compound in question, and cumulative comparisons were also performed.

Results: Cumulatively, differences in rates of sensitization between the GPMT and OET did not reach statistical significance; however, both tests produced higher sensitization rates than the Buehler test (1% significance level). Comparisons for individual compounds are outlined within GPCR Compound Library the main text.

Conclusions: Our results

indicate a possible role for the OET in the testing of weakly allergenic compounds. Similarly, the Buehler test may hold greatest utility in the examination of strongly allergenic compounds, where high sensitivity is not necessary and limited exposure to subjects is desired. These findings may help guide experimental protocols and considerations.”
“This research study was conducted to investigate acute oral toxicity and analgesic activity of ethanol extract of P. domestica fruit by using tail flick analgesiometer at 300 and 500mg/kg doses in animal models. Acute oral toxicity results showed that crude extract is safe up to the dose of 5g/kg body weight of animals. www.sellecn.cn/products/ag-881.html The analgesic

activity revealed that P. domestica extract at 500mg/kg dose possesses highest significant and prolonged analgesic activity in dose dependent manner as compared to standard and control groups. Aspirin 300mg/kg body weight was used as standard drug. Phytochemical analysis was also carried out which showed the presence of certain phytochemicals constituents in test drug that are responsible for analgesic activity. Therefore the results are justified.”
“The goal of the studies presented here was to determine the tolerability, pharmacokinetic and pharmacodynamic profiles of CMAB007, a biosimilar of omalizumab (Xolair; a humanized anti-immunoglobulin E monoclonal antibody), in healthy, male Chinese subjects. Thirty-six healthy Chinese men participated in two open-label, dose-escalation studies: 27 in a single-dose study (150, 300 or 600 mg) and 9 in a multiple-dose study (150 or 300 mg every 4 weeks for 20 weeks). The safety profiles of both studies were generally unremarkable. No drug-related adverse event was observed. CMAB007 exhibited a linear PK profile over the dose range of 150-600 mg. In the single-dose study, maximum concentration (C-max) was reached within 6-8 d, and C-max and area under concentration-time curve (AUC) increased linearly with the dose.